← Evidence map

ArticleClinical & translational immunology2021

Ligelizumab treatment for severe asthma: learnings from the clinical development programme.

Jordis Trischler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33747510